当前位置:首页 - 行情中心 - 羚锐制药(600285) - 财务分析 - 现金流量表

羚锐制药

(600285)

  

流通市值:125.57亿  总市值:125.84亿
流通股本:5.66亿   总股本:5.67亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,017,479,983.083,898,414,517.043,065,164,136.212,035,553,754.08
  收到的税费返还-775,299.8--
  收到其他与经营活动有关的现金31,093,141.0226,701,559.9143,574,093.7633,866,177
  经营活动现金流入小计1,048,573,124.13,925,891,376.753,108,738,229.972,069,419,931.08
  购买商品、接受劳务支付的现金205,432,351.62685,446,595.1474,324,248.33294,403,477.76
  支付给职工以及为职工支付的现金96,923,725.24397,590,110.19283,353,445.18185,738,783.09
  支付的各项税费115,096,532.3534,942,951.44389,371,771.63276,716,164.12
  支付其他与经营活动有关的现金362,670,359.331,754,029,006.231,471,301,108.47956,973,999.36
  经营活动现金流出小计780,122,968.493,372,008,662.962,618,350,573.611,713,832,424.33
  经营活动产生的现金流量净额268,450,155.61553,882,713.79490,387,656.36355,587,506.75
二、投资活动产生的现金流量:
  收回投资收到的现金-29,444,100.1623,941,820.1523,941,820.15
  取得投资收益收到的现金13,123,818.4234,008,311.5121,690,815.5716,374,701.69
  处置固定资产、无形资产和其他长期资产收回的现金净额232,0007,524,585.687,185,4627,185,162
  收到的其他与投资活动有关的现金419,166,958.91,422,341,041669,378,505.22146,500,000
  投资活动现金流入小计432,522,777.321,493,318,038.35722,196,602.94194,001,683.84
  购建固定资产、无形资产和其他长期资产支付的现金13,131,261.2356,830,201.5338,225,885.1132,618,221.35
  投资支付的现金-20,000,00020,000,00020,000,000
  取得子公司及其他营业单位支付的现金-672,549,843.75672,549,843.75672,549,843.75
  支付其他与投资活动有关的现金518,000,0001,930,064,901.681,185,703,151.68397,492,610
  投资活动现金流出小计531,131,261.232,679,444,946.961,916,478,880.541,122,660,675.1
  投资活动产生的现金流量净额-98,608,483.91-1,186,126,908.61-1,194,282,277.6-928,658,991.26
三、筹资活动产生的现金流量:
  取得借款收到的现金64,245,955.83371,250,790.47517,374,558.27398,070,362.29
  筹资活动现金流入小计64,245,955.83371,250,790.47517,374,558.27398,070,362.29
  偿还债务支付的现金163,910,00070,000,00070,000,00010,000,000
  分配股利、利润或偿付利息支付的现金53,750511,285,617.96510,338,609.65509,986,252.9
  支付其他与筹资活动有关的现金64,8913,227,689.681,840,710.651,052,511.05
  筹资活动现金流出小计164,028,641584,513,307.64582,179,320.3521,038,763.95
  筹资活动产生的现金流量净额-99,782,685.17-213,262,517.17-64,804,762.03-122,968,401.66
四、汇率变动对现金及现金等价物的影响-9,302.68-27,150.54-22,131.92-18,920.46
五、现金及现金等价物净增加额70,049,683.85-845,533,862.53-768,721,515.19-696,058,806.63
  加:期初现金及现金等价物余额382,843,943.471,228,377,8061,228,377,8061,228,377,806
  期末现金及现金等价物余额452,893,627.32382,843,943.47459,656,290.81532,318,999.37
补充资料:
  净利润-762,447,855.85-475,868,499.88
  资产减值准备-608,216.19-35,682.24
  固定资产和投资性房地产折旧-67,874,069.54-33,229,438.81
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-67,874,069.54-33,229,438.81
  无形资产摊销-27,343,596.37-11,536,163.03
  长期待摊费用摊销-2,715,390.11-1,403,350.56
  处置固定资产、无形资产和其他长期资产的损失--6,993,442.94--4,703,827.72
  固定资产报废损失-5,906,974.48-93,037.72
  公允价值变动损失-7,324,507.63-1,998,717.96
  财务费用-4,142,161.02-1,608,648.59
  投资损失--49,996,026.1--24,131,253.21
  递延所得税-16,038,751.55--7,023,107.22
  其中:递延所得税资产减少-14,090,973.22--9,114,102.39
    递延所得税负债增加-1,947,778.33-2,090,995.17
  存货的减少-30,454,691.54-59,239,026.45
  经营性应收项目的减少--202,224,745.08--235,881,828.29
  经营性应付项目的增加--147,043,558.18-20,994,518.89
  其他-26,594,843.24-13,318,874.18
  现金的期末余额-382,843,943.47-532,318,999.37
  减:现金的期初余额-1,228,377,806-1,228,377,806
  现金及现金等价物的净增加额--845,533,862.53--696,058,806.63
公告日期2026-04-282026-04-282025-10-302025-08-20
审计意见(境内)标准无保留意见
TOP↑